Howard Marks / Bart Bixler
@Oaktree Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$6.239BTotal holdings167
Assets growth rate-99.9%Assets growth rate (2-Q avg)-50.46%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Oaktree Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 167 positions.
Assets under management
The assets under management (AUM) of Oaktree Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.239B in assets, with a quarterly growth rate of -99.9% and a 2-quarter average growth rate of -50.46%. The portfolio is managed by Howard Marks, Bart Bixler, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
5165⤦Lantheus Holdings Inc
| 0% | $4.866B 3.901M shares@ $1247.39 avg price | Exited |
6288⤦Norwegian Cruise Line Holdings Ltd
| 0% | $4.25B 3.489M shares@ $1218.25 avg price | Exited |
G493⤦Iqiyi Inc
| 0% | $4.198B 4.4M shares@ $954.1 avg price | Exited |
5716⤦Marriott Vacations Worldwide Corp
| 0% | $3.844B 4.201M shares@ $915.0 avg price | Exited |
3932⤦Green Plains Inc
| 0% | $3.24B 3.638M shares@ $890.67 avg price | Exited |
9004⤦Turning Point Brands Inc
| 0% | $3.232B 3.21M shares@ $1006.91 avg price | Exited |
8245⤦Shift4 Payments Inc
| 0% | $3.167B 3.335M shares@ $949.5 avg price | Exited |
0906⤦Biomarin Pharmaceutical Inc
| 0% | $2.919B 2.936M shares@ $994.3 avg price | Exited |
1630⤦Chegg Inc
| 0% | $2.789B 3.502M shares@ $796.31 avg price | Exited |
6415⤦Nevro Corp
| 0% | $2.597B 2.673M shares@ $971.51 avg price | Exited |